AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Reduction of Lipase Activity in Product Formulation

Detailed Technology Description

Downstream processing of monoclonalantibodies (mAbs) hasevolved to allow the specific process for a new product to be developed largelyby empirical specialization of a platform process that enables removal ofimpurities of different kinds. A more complete characterization of impuritiesand the product itself would provide insights into the rational design ofefficient downstream processes. This work identifies and characterizes hostcell protein (HCP) product-associated impurities, i.e., HCP species carriedthrough the downstream processes via direct interactions with the mAb.Interactions between HCP and mAbs are characterized usingcross-interaction chromatography under solution conditions typical of thoseused in downstream processing. The interacting species are then identified bytwo-dimensional gel electrophoresis and mass spectrometry. This methodology hasbeen applied to identify product-associated impurities in one particularpurification step, namely protein A affinity chromatography, for fourtherapeutic mAbs aswell as the Fab and Fc domains of one of these mAbs. The results show both the differencesin HCP-mAbinteractions among different mAbs, and the relative importance of productassociation compared to co-elution in protein A affinity chromatography

Countries

United States

Application No.

Patent Pending

Country/Region

USA

For more information, please click Here